Asset Dedication LLC’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.7K | Sell |
177
-151
| -46% | -$22.6K | ﹤0.01% | 597 |
|
|
2026
Q1 | $50.1K | Sell |
328
-100
| -23% | -$15.3K | ﹤0.01% | 478 |
|
|
2025
Q4 | $59K | Buy |
428
+100
| +30% | +$13.1K | ﹤0.01% | 475 |
|
|
2025
Q3 | $42.1K | Buy |
328
+5
| +2% | +$610 | ﹤0.01% | 544 |
|
|
2025
Q2 | $39.1K | Hold |
323
| – | – | ﹤0.01% | 564 |
|
|
2025
Q1 | $36K | Buy |
323
+20
| +7% | +$2.13K | ﹤0.01% | 532 |
|
|
2024
Q4 | $29.5K | Hold |
303
| – | – | ﹤0.01% | 566 |
|
|
2024
Q3 | $34.9K | Hold |
303
| – | – | ﹤0.01% | 570 |
|
|
2024
Q2 | $32.3K | Hold |
303
| – | – | ﹤0.01% | 571 |
|
|
2024
Q1 | $30K | Hold |
303
| – | – | ﹤0.01% | 519 |
|
|
2023
Q4 | $30K | Hold |
303
| – | – | ﹤0.01% | 504 |
|
|
2023
Q3 | $31K | Hold |
303
| – | – | ﹤0.01% | 494 |
|
|
2023
Q2 | $30K | Hold |
303
| – | – | ﹤0.01% | 503 |
|
|
2023
Q1 | $28K | Hold |
303
| – | – | ﹤0.01% | 498 |
|
|
2022
Q4 | $28K | Buy |
303
+107
| +55% | +$9.01K | ﹤0.01% | 497 |
|
|
2022
Q3 | $15K | Hold |
196
| – | – | ﹤0.01% | 563 |
|
|
2022
Q2 | $17K | Hold |
196
| – | – | ﹤0.01% | 301 |
|
|
2022
Q1 | $17K | Sell |
196
-224
| -53% | -$19.4K | ﹤0.01% | 583 |
|
|
2021
Q4 | $36K | Sell |
420
-260
| -38% | -$21.6K | ﹤0.01% | 461 |
|
|
2021
Q3 | $54K | Hold |
680
| – | – | 0.01% | 403 |
|
|
2021
Q2 | $61K | Hold |
680
| – | – | 0.01% | 363 |
|
|
2021
Q1 | $59K | Buy |
680
+400
| +143% | +$35.9K | 0.01% | 311 |
|
|
2020
Q4 | $27K | Hold |
280
| – | – | 0.01% | 426 |
|
|
2020
Q3 | $25K | Hold |
280
| – | – | 0.01% | 409 |
|
|
2020
Q2 | $25K | Hold |
280
| – | – | 0.01% | 376 |
|
|
2020
Q1 | $23K | Sell |
280
-87
| -24% | -$7.76K | 0.01% | 382 |
|
|
2019
Q4 | $35K | Buy |
367
+87
| +31% | +$7.81K | 0.01% | 330 |
|
|
2019
Q3 | $25K | Sell |
280
-24
| -8% | -$2.15K | 0.01% | 364 |
|
|
2019
Q2 | $27K | Buy |
304
+133
| +78% | +$11.3K | 0.01% | 337 |
|
|
2019
Q1 | $15K | Hold |
171
| – | – | 0.01% | 406 |
|
|
2018
Q4 | $14K | Hold |
171
| – | – | 0.01% | 395 |
|
|
2018
Q3 | $14K | Hold |
171
| – | – | 0.01% | 401 |
|
|
2018
Q2 | $11K | Sell |
171
-83
| -33% | -$5.73K | ﹤0.01% | 434 |
|
|
2018
Q1 | $18K | Buy |
254
+234
| +1,170% | +$17.8K | 0.01% | 328 |
|
|
2017
Q4 | $2K | Buy |
+20
| New | +$1.51K | ﹤0.01% | 451 |
|
|
2016
Q2 | – | Sell |
-29
| Closed | -$2K | – | 424 |
|
|
2016
Q1 | $2K | Hold |
29
| – | – | ﹤0.01% | 376 |
|
|
2015
Q4 | $2K | Buy |
+29
| New | +$2.3K | ﹤0.01% | 572 |
|
Other funds holding NVS
Asset Dedication LLC's NVS Position: Q2 2026 in Review
Asset Dedication LLC reduced its Novartis (NVS) stake by 46% in Q2 2026, selling an estimated $22.6K and leaving 177 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #597.
Asset Dedication LLC first reported a position in NVS in Q4 2015 and has held it in 37 quarters since. The position peaked at $61K in Q2 2021. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Asset Dedication LLC held 177 shares of Novartis worth $27.7K as of Q2 2026.
- Asset Dedication LLC sold 151 Novartis shares in Q2 2026, an estimated $22.6K.
- Novartis made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #597 holding.
- Asset Dedication LLC first reported a position in Novartis in Q4 2015 and has held it in 37 quarters since.
- Asset Dedication LLC's Novartis position peaked at $61K in Q2 2021.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.